INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 74 filers reported holding INOZYME PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.65 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 617,459 | $3,439,246 | 0.00% |
STATE STREET CORP | 560,842 | $3,123,890 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 17,100 | $95 | 0.00% |
CITIGROUP INC | 10,080 | $56,146 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 88,257 | $491,591 | 0.00% |
GOLDMAN SACHS GROUP INC | 34,389 | $191,547 | 0.00% |
MORGAN STANLEY | 33,585 | $187,069 | 0.00% |
Invesco Ltd. | 13,048 | $72,678 | 0.00% |
AMALGAMATED BANK | 3,292 | $18 | 0.00% |
BlackRock Inc. | 1,939,660 | $10,803,906 | 0.00% |
Bank of New York Mellon Corp | 141,704 | $789,291 | 0.00% |
Citadel Advisors | 3,000 | $16,710 | 0.00% |
Citadel Advisors | 21,100 | $117,527 | 0.00% |
Citadel Advisors | 145,600 | $810,992 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,600 | $81,322 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25,500 | $142,035 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,404 | $91,370 | 0.00% |
SIMPLEX TRADING, LLC | 72 | $0 | 0.00% |
External links
This page lists INOZYME PHARMA INC's shareholders in Q2 2023. To view INOZYME PHARMA INC's shareholder history, click here.